Group One Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,602,000
| Closed | -$1.42M | – | 8298 |
|
|
2022
Q4 | $1.42M | Sell |
1,602,000
-7,400
| -0.5% | -$9.82K | ﹤0.01% | 2123 |
|
|
2022
Q3 | $2.53M | Sell |
1,609,400
-191,900
| -11% | -$435K | 0.01% | 1705 |
|
|
2022
Q2 | $3.62M | Sell |
1,801,300
-61,000
| -3% | -$105K | 0.01% | 1543 |
|
|
2022
Q1 | $4.34M | Sell |
1,862,300
-3,388,400
| -65% | -$10.6M | ﹤0.01% | 1662 |
|
|
2021
Q4 | $24.4M | Buy |
5,250,700
+282,300
| +6% | +$1.75M | 0.02% | 585 |
|
|
2021
Q3 | $37.9M | Buy |
4,968,400
+204,200
| +4% | +$1.73M | 0.04% | 367 |
|
|
2021
Q2 | $46.2M | Sell |
4,764,200
-658,200
| -12% | -$5.24M | 0.06% | 276 |
|
|
2021
Q1 | $44.8M | Sell |
5,422,400
-1,483,500
| -21% | -$15.7M | 0.07% | 256 |
|
|
2020
Q4 | $47.1M | Buy |
6,905,900
+1,456,300
| +27% | +$11.7M | 0.08% | 198 |
|
|
2020
Q3 | $60.8M | Buy |
5,449,600
+2,737,200
| +101% | +$25.1M | 0.19% | 74 |
|
|
2020
Q2 | $17M | Buy |
2,712,400
+2,178,100
| +408% | +$8.34M | 0.08% | 267 |
|
|
2020
Q1 | $983K | Buy |
534,300
+195,900
| +58% | +$564K | 0.01% | 1537 |
|
|
2019
Q4 | $1.14M | Buy |
338,400
+82,200
| +32% | +$196K | 0.01% | 1759 |
|
|
2019
Q3 | $548K | Sell |
256,200
-16,100
| -6% | -$37.5K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $727K | Buy |
272,300
+40,900
| +18% | +$147K | 0.01% | 1819 |
|
|
2019
Q1 | $1.1M | Buy |
231,400
+207,800
| +881% | +$545K | 0.01% | 1340 |
|
|
2018
Q4 | $57K | Buy |
23,600
+21,200
| +883% | +$69.2K | ﹤0.01% | 3493 |
|
|
2018
Q3 | $11K | Sell |
2,400
-81,700
| -97% | -$453K | ﹤0.01% | 4634 |
|
|
2018
Q2 | $606K | Sell |
84,100
-82,100
| -49% | -$558K | 0.01% | 2141 |
|
|
2018
Q1 | $856K | Buy |
166,200
+141,000
| +560% | +$1M | 0.01% | 1641 |
|
|
2017
Q4 | $96K | Buy |
25,200
+21,700
| +620% | +$56.5K | ﹤0.01% | 3388 |
|
|
2017
Q3 | $6K | Buy |
+3,500
| New | +$6.42K | ﹤0.01% | 4445 |
|
|
2017
Q2 | – | Sell |
-4,100
| Closed | -$16K | – | 5231 |
|
|
2017
Q1 | $16K | Hold |
4,100
| – | – | ﹤0.01% | 3969 |
|
|
2016
Q4 | $20K | Sell |
4,100
-18,300
| -82% | -$110K | ﹤0.01% | 3705 |
|
|
2016
Q3 | $173K | Buy |
22,400
+4,900
| +28% | +$33K | ﹤0.01% | 2570 |
|
|
2016
Q2 | $98K | Buy |
17,500
+15,000
| +600% | +$95.9K | ﹤0.01% | 2880 |
|
|
2016
Q1 | $13K | Sell |
2,500
-57,000
| -96% | -$331K | ﹤0.01% | 3929 |
|
|
2015
Q4 | $518K | Sell |
59,500
-75,000
| -56% | -$633K | 0.01% | 1797 |
|
|
2015
Q3 | $1.13M | Buy |
134,500
+127,300
| +1,768% | +$2.03M | 0.02% | 1152 |
|
|
2015
Q2 | $127K | Buy |
7,200
+6,500
| +929% | +$83.5K | ﹤0.01% | 2893 |
|
|
2015
Q1 | $8K | Buy |
+700
| New | +$8.1K | ﹤0.01% | 4240 |
|
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM
Group One Trading's SRNE Position: Q4 2020 in Review
Group One Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2020, closing a stake of 3,697 shares — an estimated $29.7K sold.
Group One Trading first reported a position in SRNE in Q1 2015 and held it in 15 quarters. The position peaked at $391K in Q3 2018. 219 funds tracked by Wall St. Rank hold SRNE as of Q4 2020.
- Group One Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
- Group One Trading sold 3,697 Sorrento Therapeutics, Inc. shares in Q4 2020, an estimated $29.7K.
- Group One Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 15 quarters.
- Group One Trading's Sorrento Therapeutics, Inc. position peaked at $391K in Q3 2018.
- 219 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2020.
Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.